Skip to content
PICO Portalanswers from OpenAlex

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma

PaperCitations, authors & open-access status

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma is a paper indexed in PICO Portal from OpenAlex.

How many citations does Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma have?

PICO Portalcitation count

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma has 3,653 citations in the OpenAlex counts PICO Portal stores.

When was Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma published?

PICO Portalyear

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma has 2007 year in the PICO Portal index.

What is the open-access status of Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma?

PICO Portaloa status

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma has closed oa status in the PICO Portal index.

What is the DOI of Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma?

PICO Portaldoi

The DOI for Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma is on the source record.

What is the PMID of Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma?

PICO Portalpmid

The PMID for Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma is on the source record.

What is the OpenAlex record for Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma?

PICO Portalopenalex

The OpenAlex for Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial